Borealis VenturesFirm match from fund name (lower confidence)
Borealis Fund VI, LP
Late investment period: first sale May 2022, per Form D (fund age approximates vintage)
- Vintage
- 2022
- Fund size
- $5.29M to $100M (Form D)
- Stages
- Not stated
- Sectors
- Biotech, Digital health, Healthtech
- Regions
- US, Global
01 · Thesis
Borealis Ventures partners closely with exceptional entrepreneurs to build market-defining companies. It focuses on transforming healthcare through new therapies, digital innovation, and other technologies, investing at the earliest stages as lifecycle investors across life science platforms, digital health, and animal health.Inferred from the firm's website
02 · Initial check
$53K to $1.67M (estimated from fund size)
Estimated from Form D: $5.29M sold of a $100M target
03 · Who to approach
Named on this fund's Form D
- Ben Shaw, Partner
- Philip Ferneau, Manager of the Issuer's General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideBorealis Ventures partners closely with exceptional entrepreneurs to build market-defining companies focused on transforming healthcare through new therapies, digital innovation, and other technologies.
Borealis Ventures partners closely with exceptional entrepreneurs to build market-defining companies.
https://www.borealis.vc/about
06 · Sources
Last verified: Oct 28, 2026